API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Historical End-of-Day API Real-time Prices API Financial Events & News API Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 152 articles Forum Github 14 repos
Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. FOREX /
  3. MYRCNY.FOREX

MYR/CNY (MYRCNY FOREX) stock market data APIs

1.6203 -0(-0%) as of November 23, 2024

MYR/CNY Financial Data Overview

1.6213
1.6203
0
1.6243
1.6174
1.469 - 1.702
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

Get MYR/CNY Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get MYR/CNY End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get MYR/CNY latest news via APIs

INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - PAND, PRAH, AEGN, PTVCA, CRHM, CBLI, AKER

NEW YORK, Feb. 25, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: (PRNewsfoto/Halper Sadeh LLP) Pandion Therapeutics, Inc.(NASDAQ: PAND) concerning potential violations of the federal securities laws and/or breaches o...
  • FEDERAL SECURITIES LAWS

MyMD Pharmaceuticals Announces New Data on Its Lead Compound MYMD-1 from a Phenotypic Study Performed by Eurofins Discovery

Data from the translationally relevant study reported ability of MYMD-1 to inhibit key biomarkers associated with fibrotic diseases including idiopathic pulmonary fibrosis (IPF) and interstitial lung disease (ILD) Eurofins Discovery human phenotypic screening platform revealed potential of MYMD-1to...
  • AKERS BIOSCIENCES
  • EUROFINS
  • EUROFINS DISCOVERY
  • IDIOPATHIC PULMONARY FIBROSIS
  • INC
  • INTERSTITIAL LUNG DISEASE
  • MYMD
  • MYMD PHARMACEUTICALS
News API is available at any package from $19.99 See full price
Get sample of News API
Do you have any questions?
support@eodhistoricaldata.com